ACER - Acer Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.69
52-Week Change 3-86.46%
S&P500 52-Week Change 39.71%
52 Week High 328.2500
52 Week Low 31.8700
50-Day Moving Average 33.0971
200-Day Moving Average 39.6816

Share Statistics

Avg Vol (3 month) 3115.96k
Avg Vol (10 day) 346.63k
Shares Outstanding 510.1M
Float 3.46M
% Held by Insiders 119.02%
% Held by Institutions 159.17%
Shares Short (Sep 30, 2019) 4749.38k
Short Ratio (Sep 30, 2019) 46.32
Short % of Float (Sep 30, 2019) 413.58%
Short % of Shares Outstanding (Sep 30, 2019) 47.42%
Shares Short (prior month Aug 30, 2019) 4729.5k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21000/96
Last Split Date 3Sep 21, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-77.25%
Return on Equity (ttm)-151.27%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-31.47M
Diluted EPS (ttm)-3.1950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.49M
Total Cash Per Share (mrq)2.33
Total Debt (mrq)537.97k
Total Debt/Equity (mrq)1.95
Current Ratio (mrq)4.92
Book Value Per Share (mrq)2.73

Cash Flow Statement

Operating Cash Flow (ttm)-27.48M
Levered Free Cash Flow (ttm)-15.44M